Sort
39,280 grants matching “leukemia”
Mechanisms of T cell leukemia induction and maintenance
$319,746Iannis Aifantis · New York University School Of Medicine · R01 · FY2013 · CA
Cell Cycle Regulation and Leukemogenesis by CBFb-SMMHC
$319,714Alan D Friedman · Johns Hopkins University · R01 · FY2006 · CA
Recognition and Segregation of Broken Chromosomes
$319,701David P Toczyski · University Of California, San Francisco · R01 · FY2006 · GM
MICROGLIA IN RETROVIRUS INDUCED NEURODEGENERATION
$319,700Northeastern Ohio Universities Coll Med · R01 · FY2005 · NS
MICROGLIA IN RETROVIRUS INDUCED NEURODEGENERATION
$319,700Northeastern Ohio Universities Coll Med · R01 · FY2004 · NS
MICROGLIA IN RETROVIRUS INDUCED NEURODEGENERATION
$319,700Northeastern Ohio Universities Coll Med · R01 · FY2003 · NS
LIF and Cell Renewal in Hippocampus and Olfactory Bulb
$319,691Paul H Patterson · California Institute Of Technology · R01 · FY2007 · NS
Targeting protein-protein interactions of Bmi1 oncoprotein
$319,688Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Targeting protein-protein interactions of Bmi1 oncoprotein
$319,688Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2016 · CA
Targeting protein-protein interactions of Bmi1 oncoprotein
$319,688Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Cancer and Leukemia Group B
$319,678University Of Chicago · U10 · FY2003 · CA
Genotoxicity & Emergence of Genome Instability in Humans
$319,620Barry A Finette · University Of Vermont & St Agric College · R01 · FY2007 · CA
Function of Myeloid Translocation Gene Related-1
$319,599Scott Hiebert · Vanderbilt University · R01 · FY2008 · CA
Mechanisms mediating immune response upon sensing of nuclear viral DNA
$319,562Ileana M. Cristea · Princeton University · R01 · FY2017 · GM
Functions of E2A in B Lymphocyte Development
$319,559Yuan Zhuang · Duke University · R01 · FY2006 · CA
HES1 mediates cell-specific consequences of Notch signaling in ALL
$319,550Patrick A Zweidler-McKay · University Of Tx Md Anderson Can Ctr · R01 · FY2010 · CA
Genetic Manipulation of T Cells--PreClinical Models
$319,550Washington University · R01 · FY2002 · CA
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
$319,550Jeffrey Wallace Tyner · Oregon Health & Science University · R01 · FY2015 · CA
Novel monocyte effector function in CLL immune therapy
$319,550Susheela Tridandapani · Ohio State University · R01 · FY2015 · CA
Developing CRM1 inhibitors in AML
$319,550Ramiro Garzon · Ohio State University · R01 · FY2015 · CA
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
$319,550Jeffrey Wallace Tyner · Oregon Health & Science University · R01 · FY2014 · CA
CHARACTERIZATION OF RECURRENT ADJACENT GENE TRANSLOCATIONS IN BREAST CANCER
$319,550Xiaosong Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · CA
Developing CRM1 inhibitors in AML
$319,550Ramiro Garzon · Ohio State University · R01 · FY2014 · CA
Developing CRM1 inhibitors in AML
$319,550Ramiro Garzon · Ohio State University · R01 · FY2017 · CA
Role of Shp2 in FLT3-ITD-Induced Leukemogenesis
$319,550Rebecca J Chan · Indiana University Indianapolis · R01 · FY2012 · CA